* Zepp Health Corp ZEPP.N ZEPP.K is expected to show a fall
in quarterly revenue when it reports results on May 13 .
* The Hefei, Anhui-based company is expected to report a
1.6% decrease in revenue to CNY1.071 billion from CNY1.09
billion a year ago, according to the estimate from one analyst,
based on Refinitiv data.
* Refinitiv's mean analyst estimate for Zepp Health Corp is for
earnings of 49 fen per share. For the same quarter last year,
the company reported earnings of 39 fen per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 2 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in the
last three months.
* Wall Street's median 12-month price target for Zepp Health
Corp is $13.7, about 32.3% above its last closing price
of $9.27.
* Previous quarterly performance (using preferred earnings
measure in Chinese yuan renminbi).
QUARTER STARMINE REFINITIV ACTUAL BEAT, SURPRI
ENDING SMARTESTIM IBES MET, SE %
ATE® ESTIMATE MISSED
Dec. 31 2020 1.43 1.43 1.96 Beat 37.4
Sep. 30 2020 2.56 2.62 1.85 Missed -29.4
Jun. 30 2020 0.35 0.35 0.30 Missed -14.9
Mar. 31 2020 1.00 1.17 0.39 Missed -66.6
Dec. 3.42 3.04 3.31 Beat 8.9
31 2019
Sep. 30 2019 2.70 2.70 3.25 Beat 20.4
Jun. 30 2019 1.72 1.72 1.73 Missed 0.6
Mar. 31 2019 0.64 0.64 0.22 Beat 132.8
This summary was machine generated May 11 at 14:34 GMT. All
figures in Chinese yuan renminbi unless otherwise stated